MAPT and tauopathy: Understanding the mechanisms by which activation of the WldS-protective pathway negates tau-mediated axonal degeneration could yield important insight into how axons degenerate in tauopathy and other similar chronic degenerative conditions and provide novel disease-modifying targets that emulate this protective effect.